Amalgamated Bank Seagen Inc. Transaction History

Amalgamated Bank

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$191.51 - $216.16 $95,755 - $108,080	-500 Reduced 3.3%	14,656 $3.11 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $83,875 - $92,193	-447 Reduced 2.86%	15,156 $2.92 Million
Q1 2023 May 02, 2023	BUY	$127.59 - $203.08 $47,846 - $76,155	375 Added 2.46%	15,603 $3.16 Million
Q4 2022 Feb 10, 2023	BUY	$117.37 - $139.17 $2,699 - $3,200	23 Added 0.15%	15,228 $1.96 Million
Q3 2022 Nov 09, 2022	BUY	$135.27 - $180.11 $28,136 - $37,462	208 Added 1.39%	15,205 $2.08 Million

Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $10,663 - $17,574	98 Added 0.66%	14,997 $2.65 Million
Q1 2022 Jun 30, 2022	BUY	$119.61 - $157.85 $343,998 - $453,976	2,876 Added 23.92%	14,899 $2.15 Million
Q4 2021 Feb 15, 2022	BUY	$142.57 - $190.86 $513,394 - $687,286	3,601 Added 42.76%	12,023 $1.86 Million
Q3 2021 Oct 29, 2021	SELL	$142.45 - $169.82 $184,330 - $219,747	-1,294 Reduced 13.32%	8,422 $1.43 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $469,943 - $560,466	3,479 Added 55.78%	9,716 $1.53 Million
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $51,016 - $70,786	-371 Reduced 5.61%	6,237 $866,000
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $1.09 Million - $1.4 Million	6,608 New	6,608 $1.16 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.